Profile data is unavailable for this security.
About the company
Thiogenesis Therapeutics, Corp. is a Canada-based clinical-stage biopharmaceutical company. The Company is engaged in developing thiol-active therapeutic compounds, which are prodrugs used to treat unmet pediatric medical needs. The Company’s lead compound, TTI-0102, is a disulfide, made up of two thiols that lead to two independent cysteamine molecules. Cysteamine is a thiol that has been rigorously studied and tested. It is the active ingredient used in drugs to treat the lysosomal storage disease - (nephropathic) cystinosis. TTI-0102 has been developed to address the important obstacles facing thiol-based drugs, their short half-life, strong gastrointestinal (GI) side-effects and dosing limitations. As a prodrug, TTI-0102 is metabolized into cysteamine molecules after it is ingested. The metabolic process acts as a gating mechanism. TTI-0102’s initial applications are for mitochondrial disease, Rett syndrome and pediatric non-alcoholic steatohepatitis (NASH).
- Revenue in CAD (TTM)0.00
- Net income in CAD-4.71m
- Incorporated2018
- Employees--
- LocationThiogenesis Therapeutics Corp4 King Street West, Suite 401Toronto M5H 1B6CanadaCAN
- Phone+1 (647) 846-7766
- Websitehttps://www.thiogenesis.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmacielo Ltd | 2.81m | -12.82m | 26.31m | 268.00 | -- | 9.04 | -- | 9.36 | -0.082 | -0.082 | 0.018 | 0.0172 | 0.1046 | 1.27 | 18.23 | -- | -47.70 | -- | -67.05 | -- | -7.08 | -- | -456.04 | -- | 0.1712 | -4.01 | 0.8578 | -- | 172.93 | -- | 45.49 | -- | -- | -- |
| Decibel Cannabis Company Inc | 109.77m | -1.05m | 26.59m | -- | -- | 0.6196 | 12.71 | 0.2422 | -0.0027 | -0.011 | 0.2567 | 0.1049 | 0.7868 | 1.36 | 8.13 | -- | -0.749 | -3.55 | -1.24 | -5.19 | 38.79 | 38.83 | -0.952 | -7.13 | 0.4277 | 1.58 | 0.5247 | -- | 46.18 | -- | 60.33 | -- | -32.45 | -- |
| Avicanna Inc | 22.07m | -7.25m | 26.84m | 38.00 | -- | -- | -- | 1.22 | -0.0808 | -0.0808 | 0.2477 | -0.0055 | 1.12 | 3.07 | 12.26 | 580,708.40 | -36.83 | -67.17 | -282.36 | -167.73 | 47.29 | 46.36 | -32.86 | -368.82 | 0.3163 | -10.44 | 0.1834 | -- | 314.82 | 169.57 | 40.67 | -- | -32.29 | -- |
| Medipharm Labs Corp | 36.99m | -13.61m | 28.28m | 166.00 | -- | 0.5673 | -- | 0.7646 | -0.0382 | -0.0382 | 0.1017 | 0.1234 | 0.600 | 3.44 | 3.90 | 222,831.30 | -22.07 | -32.88 | -26.27 | -39.56 | 16.37 | -5.88 | -36.78 | -67.66 | 2.20 | -- | 0.0407 | -- | 49.49 | 26.52 | 56.37 | -- | -49.66 | -- |
| Medicus Pharma Ltd | 0.00 | -10.46m | 28.57m | -- | -- | -- | -- | -- | -1.40 | -1.40 | 0.00 | -0.0518 | 0.00 | -- | -- | -- | -1,549.38 | -652.37 | -- | -- | -- | -- | -- | -- | -- | -13.22 | -- | -- | -- | -- | -300.86 | -- | -- | -- |
| Charlotte's Web Holdings Inc | 79.86m | -41.82m | 29.85m | 164.00 | -- | 0.4667 | -- | 0.3738 | -0.2726 | -0.2726 | 0.5202 | 0.4068 | 0.3668 | 1.07 | 27.08 | 486,937.00 | -19.21 | -25.71 | -22.16 | -29.03 | 55.88 | 48.98 | -52.37 | -63.11 | 2.33 | -- | 0.478 | -- | -14.82 | -1.90 | 59.88 | -- | -7.88 | -- |
| Thiogenesis Therapeutics Corp | 0.00 | -4.71m | 31.85m | -- | -- | 5.96 | -- | -- | -0.1173 | -0.1173 | 0.00 | 0.1175 | 0.00 | -- | -- | -- | -85.31 | -- | -90.24 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- |
| Briacell Therapeutics Corp | 0.00 | -8.22m | 36.54m | 5.00 | -- | -- | -- | -- | -0.5363 | -0.5363 | 0.00 | -0.5115 | 0.00 | -- | -- | -- | -33.97 | -59.37 | -43.50 | -63.11 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 24.35 | -- | -- | -- |
| Immunoprecise Antibodies Ltd | 23.65m | -14.25m | 37.12m | 102.00 | -- | 0.7459 | -- | 1.57 | -0.413 | -0.413 | 0.6847 | 1.38 | 0.2939 | 5.25 | 6.76 | 169,388.60 | -17.70 | -23.62 | -19.62 | -27.25 | 51.88 | 57.18 | -60.23 | -76.18 | 1.38 | -- | 0.2241 | -- | 6.72 | 30.59 | -58.96 | -- | 34.04 | -- |
| Auxly Cannabis Group Inc | 102.35m | -60.27m | 37.59m | 369.00 | -- | 0.3607 | -- | 0.3673 | -0.0596 | -0.0596 | 0.1017 | 0.0832 | 0.3454 | 2.26 | 5.92 | 277,374.00 | -20.34 | -21.47 | -30.18 | -24.99 | 7.93 | 5.08 | -58.89 | -124.15 | 0.3836 | -1.40 | 0.4399 | -- | 6.99 | 166.85 | 65.84 | -- | -40.92 | -- |
| Medexus Pharmaceuticals Inc | 158.60m | 8.06m | 39.10m | 98.00 | 4.38 | 0.965 | 2.43 | 0.2465 | 0.3651 | 0.3651 | 7.29 | 1.66 | 0.7547 | 2.19 | 5.44 | 1,618,379.00 | 3.83 | -6.83 | 8.44 | -9.79 | 52.91 | 53.90 | 5.08 | -11.45 | 0.7013 | 0.9426 | 0.6388 | -- | 40.93 | 69.17 | 142.41 | -- | -8.59 | -- |
